Akebia Therapeutics | AKBA - 流动负债



金融业
股票价格
USD
资产
USD 349.66M
现金及等价物
USD 155.55M
销售成本
USD 10.34M
流动资产
USD 229.55M
流动负债
USD 160.87M
债务
USD 46.51M
股息收益率
0
EBIT
USD -5.45M
EBITDA
USD 14.03M
员工
167
EPS每股收益
USD -0.04
股本和储备
USD 25.02M
销售毛利
USD 47.28M
债务利息支出
349.66M
贷款资金
USD 24.75M
市值
USD 182.4M
净收入
USD -12.24M
营业费用
USD 63.08M
营业利润
USD -5.45M
普通股股本
USD 265.43M
PE价格收益
1.63K
税前利润
USD -11.24M
销售收入
USD 57.62M
销售和管理费用
USD 23.53M
股票
USD 13.02M
贸易债权人
USD 9.42M
应收帐款人
USD 47.03M


流动负债 更改 日
Acadia Pharmaceuticals USD 361.44M 55.91M 2026-06
Agios Pharmaceuticals USD 70.22M 11.37M 2026-06
Akebia Therapeutics USD 160.86M 13.02M 2026-06
Alnylam Pharmaceuticals USD 1.51B 163.04M 2026-06
Amgen USD 25.5B 547M 2026-06
Ardelyx USD 109.57M 20.96M 2026-03
Astellas Pharma JPY 1.23T 16.36B 2026-06
AstraZeneca USD 31.55B 1.02B 2026-06
Bayer EUR 32.27B 1.19B 2026-06
BioMarin Pharmaceutical USD 1.66B 870.84M 2026-06
Celltrion KRW 292.71B 9.09B 2026-03
Cspc Pharmaceutical CNY 10.18B 65.36M 2025-12
Deva Holding AS TRY 6.43B 1.18B 2023-09
Dianthus Therapeutics USD 34.39M 3.89M 2026-06
Exelixis USD 361.93M 9.05M 2026-06
Fresenius Medical Care EUR 7.18B 448.03M 2026-06
GlaxoSmithKline GBP 21.53B 895M 2026-06
Ionis Pharmaceuticals USD 315.64M 401.36M 2026-06
Ironwood Pharmaceuticals USD 236.31M 5.91M 2026-03
J&J USD 54.9B 2.82B 2026-06
Kangmei Pharma CNY 5.38B 433.79M 2026-03
Karyopharm Therapeutics USD 117.3M 25.24M 2026-03
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Laboratorios Farma EUR 199.84M 121.75M 2023-12
Lexicon Pharmaceuticals USD 9.9M 10.97M 2026-03
Malin Corporation EUR 1000K 500K 2024-12
Medical Developments International AUD 5.56M 2.26M 2025-12
Moderna USD 2.53B 139M 2026-06
Nektar Therapeutics USD 57.71M 4.17M 2026-03
Neuren Pharmaceuticals AUD 4.34M 3.58M 2025-12
Organigram Holdings CAD 88.74M 5.31M 2026-03
Ovoca Bio EUR 1.3M 1.11M 2025-12
Pharma Mar EUR 98.42M 9.2M 2026-06
Prothena USD 11.66M 20.86M 2026-06
PTC Therapeutics USD 771.07M 152.54M 2026-06
Qiagen NV USD 581.45M 102.34M 2026-06
Regeneron Pharmaceuticals USD 5.53B 422.9M 2026-06
Roche Holding CHF 28.85B 846M 2026-06
Sanofi EUR 31.93B 1.92B 2026-06
Sarepta Therapeutics USD 502.91M 3.74M 2026-06
Sartorius EUR 1.44B 668.7M 2026-06
Sino Biopharmaceutical CNY 24.85B 5.29B 2025-06
Tectonic Therapeutic USD 12.96M 3.29M 2026-03
Tilray USD 259.32M 8.32M 2025-09
Vanda Pharmaceuticals USD 145.16M 27.29M 2025-12
Zealand Pharma A/S 404M 260.96M 2026-03
Zz Pientze Pharmaceu CNY 2.28B 134.52M 2026-03